The Annals of Clinical and Analytical Medicine (ACAM) remains dedicated to transparency, editorial independence, and adherence to the highest ethical and methodological standards in medical publishing. In line with international best practices, this annual report summarizes the journal’s editorial performance for the year 2024, including submission volumes, peer review processes, acceptance rates, and editorial board composition.

• Review model: Double-blind, multi-reviewer evaluation.
• Editorial pre-screening (technical/ethical check): Average 3 days.
• Time to first decision: Average 14 days.
• Average acceptance time (submission to acceptance): 61 days.
• Production time (acceptance to publication): 58 days.

• Total submissions: 950 manuscripts.
• Articles published: 180 manuscripts.
• Overall acceptance rate: 18.9% (180/950).
• Accepted after first revision: 95 articles (52.8%).
• Accepted after two or more revisions: 85 articles (47.2%).
• Article types: All published manuscripts in 2024 were Original Research Articles. The journal, however, continues to welcome case reports, reviews, and short communications.
• Editorial independence: Only 3 out of 180 published manuscripts (1.7%) originated from editorial board members; these were managed by an independent external editor under the standard double-blind peer review process.

• Plagiarism and similarity screening: All manuscripts, including abstracts and references, were checked using advanced similarity detection software.
• Research and publication ethics: Ethical approval and informed consent were mandatory for human and animal studies.
• Conflicts of interest and funding: All authors completed the ICMJE disclosure form; funding sources and sponsor roles were transparently reported.
• Data availability and transparency: Authors were encouraged to provide data availability statements and deposit datasets in open repositories when possible.

The 2024 Editorial Board of ACAM demonstrates broad international representation, ensuring diversity of expertise and perspectives. The geographical distribution is as follows:

• Turkey: 9 members
• Saudi Arabia: 6 members
• Egypt: 3 members
• Vietnam: 2 members
• Pakistan: 1 member
• Romania: 1 member

Total: 22 editorial board members from diverse countries contributed to the journal in 2024. This distribution underscores ACAM’s global reach and commitment to international collaboration.

• Further reduction of review and production timelines.
• Strengthening international diversity among authors, reviewers, and editors.
• Enhancing visibility and impact through expanded indexing (Web of Science, PubMed Central, DOAJ, Crossref).
• Encouraging research with methodological rigor, adequate sample sizes, and transparent data reporting.

The 2024 Annual Editorial Report reflects ACAM’s continued commitment to scientific rigor, ethical responsibility, and transparent reporting. By regularly disclosing editorial performance data, the journal strengthens its trustworthiness, enhances its international reputation, and contributes meaningfully to the reliability of the global medical literature.